Skip to main content
Clinical Trials/NCT05758870
NCT05758870
Not Yet Recruiting
N/A

Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai Jiao Tong University Affiliated Sixth People's Hospital0 sites64 target enrollmentApril 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Rib Fracture Multiple
Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Enrollment
64
Primary Endpoint
EQ-5D-5L
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to explore the difference between the clinical effects of surgical and non-surgical treatment for patients with low rib fracture, and to explore whether SSRF has more clinical treatment advantages in patients with low rib fracture in a randomized, controlled and prospective manner.

Registry
clinicaltrials.gov
Start Date
April 1, 2023
End Date
December 31, 2025
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Wu Weiming

Thoracic Surgery

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with chest trauma only and unilateral low rib fractures Three rib fractures and more Displacement of the broken end of the fracture (bicortical fracture and not in the same line) Time from injury to hospital \< 24 hours Age 18-70 ASA grade I-II Preoperative arterial oxygen partial pressure \>60mmHg, carbon dioxide partial pressure \<50mmHg The participate is volunteer in the study and sign the informed consent Pain score( Number Rating Scale, NRS) \>5 under calm breathing

Exclusion Criteria

  • Difficult airway History of esophageal reflux Myasthenia gravis Coagulation disorders Gastrointestinal ulcer Gastrointestinal bleeding Anesthetic drugs allergy history Asthma Chronic obstructive pulmonary disease Pregnant women

Outcomes

Primary Outcomes

EQ-5D-5L

Time Frame: 6 months after treatment

appraisal of life quality

Secondary Outcomes

  • Pain Score(6 months after treatment)

Similar Trials